 |
Medication Safety Officers Society 3325 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org.
Our acute care leadership has been reviewing current policies around our intrathecal injection for methotrexate. We were wondering if other sites are using filters since all components used to compound would be sterile and it would be compounded in a clean room suite. Additionally, has anyone used CSTDs for intrathecal administration or preparation of methotrexate? We haven't found any clear guidance or data on CSTD use for IT administration.
Thanks!